Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports

BACKGROUND: Tocilizumab, an interleukin-6 inhibitor is part of many international guidelines for the management of cytokine storm associated with severe coronavirus disease 2019 with observed improvements. However, this drug is not recommended during pregnancy owing to the lack of safety data. Restr...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullah, Shazia, Bashir, Nihal, Mahmood, Nageena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346777/
https://www.ncbi.nlm.nih.gov/pubmed/34364393
http://dx.doi.org/10.1186/s13256-021-03010-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346777/
https://www.ncbi.nlm.nih.gov/pubmed/34364393
http://dx.doi.org/10.1186/s13256-021-03010-1

Ejemplares similares